A clinical case report on the treatment of small cell carcinoma of the esophagus at Hanoi Medical University Hospital

Nguyen Van Hung, Do Huyen Chi, Doan Trong Tu, Pham Duy Manh, Lai Thi Dinh, Pham Dang Thuyen

Nội dung chính của bài viết

Tóm tắt

Small cell neuroendocrine carcinoma of the esophagus (SCNEC) is a rare and highly aggressive histological subtype that requires a multimodal treatment approach, including chemotherapy, surgery, and radiotherapy. Among these options, concurrent chemoradiotherapy with etoposide and cisplatin (EP) regimen is an effective treatment choice for patients with locoregional disease. We report the case of a 61-year-old male patient diagnosed with stage cT4bN2M0 SCNEC who received radiotherapy combined with EP chemotherapy. Following treatment, endoscopic evaluation revealed marked tumor regression, leaving only a residual ulcer scar, and tumor markers returned to normal levels, indicating a complete clinical response (CCR). To date, follow-up has shown no evidence of local recurrence or distant metastasis, with a progression-free survival (PFS) of 24 months. This case demonstrates the efficacy and safety of combined radiotherapy and EP chemotherapy in locoregional SCNEC, highlighting its potential to achieve CCR and prolong PFS.

Chi tiết bài viết

Tài liệu tham khảo

1. Cao W, Qin K, Li F, Chen W. Socioeconomic inequalities in cancer incidence and mortality: An analysis of GLOBOCAN 2022. Chin Med J (Engl). Jun 20 2024; 137(12): 1407-1413. doi:10.1097/cm9.0000000000003140.
2. Morgan E, Soerjomataram I, Rumgay H, et al. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 2022; 163(3): 649-658.e2. doi:10.1053/j.gastro.2022.05.054.
3. Krishnatreya M, Kataki AC, Sharma JD, Borthakur BB, Kalita M. Epidemiology of primary small cell carcinoma of the esophagus: A retrospective study. South Asian journal of cancer. Oct 2014; 3(4): 231-2. doi:10.4103/2278-330x.142993.
4. Alfayez M. Primary small cell oesophageal carcinoma: A retrospective study of different ‎treatment modalities. World journal of clinical oncology. Oct 24 2020; 11(10): 836-843. doi:10.5306/wjco.v11.i10.836.
5. Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Annals of cardiothoracic surgery. Mar 2017; 6(2): 119-130. doi:10.21037/acs.2017.03.14.
6. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). European journal of cancer (Oxford, England : 1990). Jan 2009; 45(2): 228-47. doi:10.1016/j.ejca.2008.10.026.
7. Wong AT, Shao M, Rineer J, Osborn V, Schwartz D, Schreiber D. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. Feb 1 2017; 30(2): 1-5. doi:10.1111/dote.12487.
8. Katada C, Komori S, Yoshida T, et al. A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus. Esophagus : official journal of the Japan Esophageal Society. Apr 2020; 17(2): 135-140. doi:10.1007/s10388-019-00686-9.
9. Raso MG, Bota-Rabassedas N, Wistuba, II. Pathology and Classification of SCLC. Cancers. Feb 16 2021; 13(4). doi:10.3390/cancers13040820
10. Mulayamkuzhiyil J, Joseph J, Agrawal A, Ojukwu Perdomo T, Jain S. A Rare Case of Primary Small Cell Carcinoma of the Esophagus. Journal of investigative medicine high impact case reports. Jan-Dec 2025; 13: 23247096251363010. doi:10.1177/23247096251363010.
11. Ji A, Jin R, Zhang R, Li H. Primary small cell carcinoma of the esophagus: progression in the last decade. Annals of translational medicine. Apr 2020; 8(7): 502. doi:10.21037/atm.2020.03.214.
12. Jeene PM, Geijsen ED, Muijs CT, et al. Small Cell Carcinoma of the Esophagus: A Nationwide Analysis of Treatment and Outcome at Patient Level in Locoregional Disease. American journal of clinical oncology. Jun 2019; 42(6): 534-538. doi:10.1097/coc.0000000000000546.
13. Casas F, Ferrer F, Farrús B, Casals J, Biete A. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer. Oct 15 1997;80(8):1366-72.
14. Linden PA, Towe CW, Watson TJ, et al. Mortality After Esophagectomy: Analysis of Individual Complications and Their Association with Mortality. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. Sep 2020; 24(9): 1948-1954. doi:10.1007/s11605-019-04346-2.
15. Usami S, Motoyama S, Maruyama K, et al. Small cell carcinoma of the esophagus treated with esophagectomy and following chemotherapy: case report with review of the literature. European surgical research Europaische chirurgische Forschung Recherches chirurgicales europeennes. 2010; 45(1): 41-4. doi:10.1159/000318589.